All the vsd cases with who wer e attempted for vsd device closure during december 2016 to f ebruar y 2019 were included. The polyester fabric is securely sewn to the device by polyester thread. Percutaneous perventricular device closure of ventricular septal. Pdf on may 4, 2019, chandra mani adhikari and others published initial experience of ventricular septal defect device closure in nepal find, read and cite all the research you need on researchgate. Isolated ventricular septal defect vsd is the most commonly recognized cardiac malformation accounting for approximately 30% of all forms of congenital heart disease. Book doctors appointment online, view cost for asd vsd device closure in pune practo. A ventricular septal defect vsd is a defect in the septum between the right and left ventricle. Septal defects are sometimes called a hole in the heart. Our team has extensive experience using the amplatzer duct occluder to repair pda in children. Transcatheter device closure and surgical repair are effective interventions with excellent midterm. Transcatheter closure of perimembranous ventricular septal.
Atrial septal defect asd is a form of a congenital heart defect that enables blood flow between two compartments of the heart called the left and right atria. Retrospective data of 412 elective percutaneous vsd closure of isolated. The amplatzer device is the most advanced device of its type available in the united states. According to the results, the american heart association has not recommended transcatheter device closure of pmvsd. For such patients, the amplatzer pfo occluder can prevent recurrent strokes. Background muscular vsds pose a significant surgical challenge with increased morbidity and mortality. This device passes through a small diameter sheath and can be easily retrieved or repositioned. Background our purpose was to describe a year experience with patients undergoing transcatheter device closure of unrepaired congenital or postoperative residual ventricular septal defects vsds. The amplatzer postinfarct muscular vsd occluder is a perc utaneous transcatheter occlus ion device intended for closure of postmyocardial infarct muscular vsds in patients who are not satisfactory surgical candidates. This hole causes the heart to work harder and pump more blood than normal. Most common congenital heart disease in both adults and children prevalence. Atrial and ventricular septal defects device closure in a. Abstract a lefttoright shunting muscular ventricular septal defect vsd was di agnosed. The technique of transcatheter ventricular septal defect vsd device closure may be associated with significant hemodynamic instability.
Device closure of muscular ventricular septal defects using. Patent foramen ovale and ventricular septal defect closure. About 10 min after deployment, the device displaced from the site and left to right shunt increased. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect. Successful device closure of a postinfarction ventricular. An overview of device closure of ventricular septal. Op170 ventricular septal defects vsd are the most common congenital heart disease. Perventricular device closure of a doubly committed. Aug 27, 2010 the aim of this study was to evaluate the safety and efficacy of transcatheter closure for perimembranous ventricular septal defect pmvsd and its longterm results. However, combining both of these procedures in one session has been described only by narin et al. A ventricular septal defect is a birth defect where there is an abnormal defect in the interventricular septum resulting in an abnormal communication between. In one patient with type i truncus arteriosus and subarterial vsd, closure of a wide apical defect was done to allow further surgical correction while avoiding left ventricular ventriculotomy.
A doubly committed subarterial ventricular septal defect vsd used to be a contraindication for device closure. Transcatheter closure of acute myocardial infarction vsd. B interrupted pledgetted sutures are placed full thickness at the superior margin of the defect, maintaining the pledgets on the left ventricular side c closure of the vsd with a dacron patch 68. Transcatheter device closure of perimembranous ventricular.
Perventricular closure of a perimembranous ventricular. Doctors for asd vsd device closure in pune, find doctors near you. A singlecenter experience on 1046 cases yuan bai, md, xudong xu, md, changyong li, md, jiaqi zhu, md, hong wu, md, shaopingchen,md,fengchen,md,xiaohuayou,md,xianxianzhao,md,yongwenqin,md. Contraindications the amplatzer postinfarct muscular vsd occluder is contraindicated for the following. In this initial experience, transaortic, retrograde vsd device closure using an ado i like device appears feasible and safe in patients with perimembranous vsds which a costeffective alternative to routine use of the ado ii device. Treatment of isolated ventricular septal defects in children. Intraoperative device closure of a perimembranous ventricular. The majority of patients were perimembranous vsd n. Periventricular closure of ventricular septal defects.
Pediatric pda closure devices childrens national hospital. Request pdf an overview of device closure of ventricular septal defects using the amplatzer devices ventricular septal defects vsd are the most common congenital cardiac anomalies. Exclusion criteria included case series already included in multicentre studies, sample size vsd acquired following myocardial infarction. Percutaneous closure of ventricular septal defect with an. Perventricular device closure has been widely applied in china in the past years, but not in a doubly committed subarterial vsd.
Particularly in the treatment of doubly committed subarterial vsd, which has been a contraindication to percutaneous transcatheter device closure because of the. Device description the amplatzer muscular vsd occluder is a selfexpanding, doubledisc device made from a nitinol wire mesh. The septum is a wall that separates the hearts left and right sides. Introduction percutaneous device closure of perimembranous ventricular septal defect pmvsd has been widely accepted and also associated with excellent rates of closure. Pdf transcatheter device closure of muscular ventricular septal. The most common congenital heart condition is pmvsd. Standard treatment for pmvsd is open surgery, which is widely performed with minimal operative.
These properties may make it a suitable device for closure of large midmuscular defects in small children. This technique avoids the injuries caused by cpb and radiograph exposure and is not limited by the diameter of blood vessels. However, this method has been challenged for the past 10 years by percutaneous transcatheter device closure. Catheter closure of congenitalacquired muscular vsds and.
To identify suitable cases and reduce failurecomplication rates for percutaneous ventricular septal defect vsd closure, we aimed to 1 study causes of device failure and 2 compare outcomes with different vsd types and devices in a highvolume single center with limited resources. Methods and results since 1989, 170 patients median age, 3. Ahistory of infective endocarditis is another class i indication. Based on the clinical experience of a number of centers, we used the right thoracic minimal incision to right ventricle approach for intraoperative device closure of a perimembranous vsd pmvsd and compared the safety and effectiveness of this approach with that of the. The first real offpump perventricular device closure of vsd was conducted in animal experiments in 1997 under tee guidance and then applied in an infant with muscular vsd. Device closure of secundum atrial septal defects is sometimes needed in young children. Although amplatzer perimembranous ventricular septal defect pmvsd occluder st jude medical, st paul, mn, usa was introduced for transcatheter closure of pmvsd in 2003, the high incidence of complete heart block was reported 5. Its the most common congenital heart defect in the newborn. Post acute myocardial infarction ventricular septal defect vsd or rupture is a rare lethal complication and curry very high surgical mortality and morbidity 110, but interventional closure of this defects by cardiac catheterization is an excellent alternative method with much better results especially in good centers 3. Transcatheter device closure of perimembranous ventricular septal defects.
Ventricular septal defect vsd american heart association. Perventricular closure of a perimembranous ventricular septal defect, multimedia manual of cardiothoracic surgery, 20, 20, doi. Transcatheter pmvsd closure is becoming the treatment of choice in selected patients worldwide after the adoi was introduced, which is an asymmetrical doubledisc device that was first described for the closure of membranous vsd. Cardiac catheterization using a vsd closure device is a procedure to close a hole ventricular septal defect or vsd in the wall septum that separates the hearts left and right ventricles pumping chambers. Eventually, tissue growth covers the cardiac occluder or closure device and facilitates retention. Of these defects 80% involves the membranous septum. Post acute myocardial infarction ventricular septal defect vsd or rupture is a rare lethal complication and curry very high surgical mortality and morbidity 110, but interventional closure of this defects by cardiac catheterization is an. Transcatheter closure of ventricular septal defects.
Cardiac catheterization with vsd cooper university health care. Device closure of muscular ventricular septal defects. Standard treatment for pmvsd is open surgery, which is widely performed with minimal operative mortality but still carries risks, such as complete. Percutaneous device closure of asd and vsd has been well described in literature, and has now become a standard procedure.
Catheterization laborator y records f or vsd type and size, device. Since the first time when ventricular septal defect vsd was surgically closed by lillehei et al. A second attempt was made to reposition the device but failed. Ventricular septal defect vsd is the most common congenital heart defect. Transcatheter transaortic retrograde approach for the. Transcatheter device matches surgery for closure of. The 2 discs are linked together by a short waist corresponding to the size of the ventricular septal defect vsd.
To investigate the safety and efficacy of perventricular device closure of perimembranous vsd pmvsd. Trans catheter device closure tcc of postinfarction vsd pivsd trans catheter device closure tcc of postof postinfarction vsd pivsd under ga, rfa, rfv, lfa and right ijv cannulated. An overview of device closure of ventricular septal defects. Percutaneous closure of perimembranous ventricular septal.
Transcatheter versus surgical closure of perimembranous. Transcatheter device closure of congenital and postoperative. Intraoperative device closure of isolated ventricular septal defects. As the fetus grows, a wall forms to separate these two ventricles, if the wall does not completely form, a hole remains. Our case is the first case in uae with large post mi. Device closure of atrial septal defects with the amplatzer septal occluder. The objective of this study was to prospectively evaluate the safety and efficacy of the muscular vsd occluder in its clinical use to close congenital muscular vsds. Complete atrioventricular block after percutaneous device. Percutaneous device closure of perimembranous ventricular septal defect pmvsd has been widely accepted and also associated with excellent rates of closure. Complications in atrial septal defect device closure. Both surgical and percutaneous device closure of vsds have drawbacks and.
A pubmed and scopus search for studies in english on device closure of pmvsds published till endfebruary 2017 was performed. Eventually, it can work so hard that it starts to fail congestive heart failure. Before a baby is born, the right and left ventricles of its heart are not separate. We present a series of 4 patients in whom a ventricular septal defect vsd was closed with an amplatzer muscular vsd device during cardiac catheterization. This hole is known as a ventricular septal defect, or a vsd. The objectives of this study were to demonstrate the feasibility of periventricular closure of muscular vsd mvsd and paramembranous vsd. Transthoracic device closure of ventricular septal defects. Post myocardial infarction vsd device closure medcrave. Apr 07, 2004 cine fluoroscopic images in a sevenmonthold female baby with single muscular ventricular septal defect vsd, demonstrating the steps of percutaneous device closure. The issue to be viewed is clicked and the available pdf and. A 5 year old girl with a haemodynamically significant midmuscular ventricular septal defect vsd had successful transcatheter closure using the amplatzer vsd occluder.
Ventricular septal defect vsd is a common congenital heart defect in both children and adults. Subsequently, perventricular device closure of pmvsd was first reported in 2004. Device closure in patients who have suffered a previous thromboembolic stroke should be discussed with the patient or family. Minimally invasive techniques are currently in use to close atrial and ventricular septal defects vsd. Transcatheter closure of pmvsd is a recently described technique with limited results for mid to longterm followup.
As it was being observed it gradually got detached and embolised into the right ventricle. Indications for percutaneous device ventricular septal defect closure to be eligible for pc closure of a vsd, patients were required to have presented with either heart failure or failure to thrive after 3 months of age, leftside heart chamber dilation or pulmonary congestion, or both, after 1 year of age. A metaanalysis of perventricular device closure of. Patients were selected for device closure if they had 1 1 or more vsds that were ascertained to result in sufficient hemodynamic derangement to warrant intervention and 2 either a type of vsd that was technically difficult to close surgically or an overall medical condition with associated surgical risks sufficient to justify the known and. Hybrid technique for ventricular septal defect closure in a dog using.
Minimally invasive transthoracic device closure of isolated. Vsd can occur as a complication of acute myocardial infarction in approximately 1%2% of cases in the first week. On the day of the procedure, our expert pediatric cardiac anesthesiologist will place your child under sedation. Pdf traditional treatment of muscular ventricular septal defect vsd is surgical closure, but it carries considerable morbidity and mortality. Device closure should only be considered if the vsd isremote from the tricuspid valve and aorta figure 3.
Device closure of atrial septal defects with the amplatzer. Cardiopulmonary bypass cpb is instituted via the femoral vessels, which may cause injury to these vessels, especially in younger patients. Ventricular septal defect vsd is one of the most common congenital heart defects. Jan 04, 2014 apical muscular vsd patch closure via rvtomy a trabeculations overlying the vsd are taken down. Aga medical corporation amplatzer muscular vsd occluder. Exclusion criteria included case series already included in multicentre studies, sample size occluder. Post myocardial infarction vsd device closure medcrave online. Retrospective data of 412 elective percutaneous vsd closure of isolated congenital vsds between 2003 and 2017.
Transcatheter closure of a midmuscular ventricular septal. Normally, the right and left atria are separated by a septum called the interatrial septum. Percutaneous device closure of congenital isolated. A left ventricular lv angiogram in the fourchamber view, demonstrating a 6mm midmuscular vsd arrow. Jun 27, 2019 perventricular device closure is a common treatment for vsd. It is associated with a significant risk of both periinterventional and midterm complications. In suitable patients with congenital vsd, device closure may well be the preferred treatment both for muscular or perimembranous vsds and for residual defects after surgical vsd closure. With the introduction of eccentric perimembranous vsd pmvsd occluder devices, percutaneous closure of pmvsds has become an accepted alternative to surgical. Birth prevalence of congenital heart disease worldwide. A metaanalysis of perventricular device closure of perimembranous ventricular septal defect zhinuan hong1, qiang chen2, liqin huang3 and hua cao1 abstract background. An interventional approach using a device is a less invasive. Certain metallic pda, asd, vsd occluders and pfo closure devices tested for magnetic qualities were made from either 304v stainless steel or mp35n.
33 414 383 1540 796 1373 111 1595 987 1657 157 1073 675 1208 398 732 1399 1214 218 1488 824 669 1387 1596 1617 359 1555 1414 430 1576 42 1596 269 681 415 1378 44 1171 309 1170 79 224 136 1236 835 1165 324